| Literature DB >> 20823200 |
Monica Moschioni1, Carla Emolo, Massimiliano Biagini, Silvia Maccari, Werner Pansegrau, Claudio Donati, Markus Hilleringmann, Ilaria Ferlenghi, Paolo Ruggiero, Antonia Sinisi, Mariagrazia Pizza, Nathalie Norais, Michèle A Barocchi, Vega Masignani.
Abstract
Thirty percent of Streptococcus pneumoniae isolates contain pilus islet 1, coding for a pilus composed of the backbone subunit RrgB and two ancillary proteins, RrgA and RrgC. RrgA is the major determinant of in vitro adhesion associated with pilus 1, is protective in vivo in mouse models, and exists in two variants (clades I and II). Mapping of the sequence variability onto the RrgA structure predicted from X-ray data showed that the diversity was restricted to the "head" of the protein, which contains the putative binding domains, whereas the elongated "stalk" was mostly conserved. To investigate whether this variability could influence the adhesive capacity of RrgA and to map the regions important for binding, two full-length protein variants and three recombinant RrgA portions were tested for adhesion to lung epithelial cells and to purified extracellular matrix (ECM) components. The two RrgA variants displayed similar binding abilities, whereas none of the recombinant fragments adhered at levels comparable to those of the full-length protein, suggesting that proper folding and structural arrangement are crucial to retain protein functionality. Furthermore, the two RrgA variants were shown to be cross-reactive in vitro and cross-protective in vivo in a murine model of passive immunization. Taken together, these data indicate that the region implicated in adhesion and the functional epitopes responsible for the protective ability of RrgA may be conserved and that the considerable level of variation found within the "head" domain of RrgA may have been generated by immunologic pressure without impairing the functional integrity of the pilus.Entities:
Mesh:
Substances:
Year: 2010 PMID: 20823200 PMCID: PMC2981310 DOI: 10.1128/IAI.00601-10
Source DB: PubMed Journal: Infect Immun ISSN: 0019-9567 Impact factor: 3.441